PE Ratio
N/A
27 min ago
Summary:
Lineage Cell Therapeutics price to earnings ratio is not available.LCTX PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX PE Ratio Performance
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +1.9% | +15.4% | +41.0% |
| 1 m1 month | - | -33.8% | - | - |
| 3 m3 months | - | -37.5% | - | - |
| 6 m6 months | - | -38.8% | - | - |
| ytdytd | - | -47.2% | - | - |
| 1 y1 year | - | -42.4% | +15.4% | -0.6% |
| 5 y5 years | - | -36.0% | +69.4% | +967.2% |
LCTX PE Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | 18.57 | 2.13 |
Lineage Cell Therapeutics PE Ratio History
| Date | Value |
|---|
| Date | Value |
|---|---|
| 2016 | 11.28 |
FAQ
- What is the all time high PE ratio for Lineage Cell Therapeutics?
What is the all time high PE ratio for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high price to earnings ratio is 18.57